1. Introduction {#sec1-1}
===============

With the development of multidetector computed tomography and magnetic resonance imaging (MRI), the three-dimensional (3D) structure of the patient's body can be presented by these medical imaging techniques and computer-aided software engineering. The 3D structures can be converted to the interpreted surface tessellation language files for 3D printing by the computer software processing. Therefore, the 3D printing technology in modern medicine has great development in current years\[[@ref1]\]. The events of 3D printing applied in current medical practice were shown below: (1) The manufacturing of *in vitro* mechanical aids: The 3D printing technology can be used to create customized and mechanical aids to restore patient's physical control and action. Cases: Arthrogryposis multiplex congenital and paralyzed patients\[[@ref2]\]. Advantages: The small number of customized products can be manufactured. (2) The development of the customized implant molds: The required and customized metal or silicone implants can be fabricated through the molds which are obtained by the 3D printed patient's desired polymer implant models\[[@ref3],[@ref4]\]. (3) The pre-operative 3D model: By 3D printing of patient's tissue models, the more complicated or high-risk surgery can be planned in advance and the time of surgery can be shortened to decrease the surgical risk\[[@ref4]\]. In addition, 3D printing model can also facilitate the improvement of commercial products, such as artificial pelvis\[[@ref5]\]. (4) The manufacturing of customized implants: The implants were fabricated by 3D printing technology and can be used for long-term implantation. Cases: 3D printed bioresorbable airway splint for tracheobronchomalacia\[[@ref6]\], 3D printed skull implant\[[@ref7]\], hip\[[@ref8]\], pelvis\[[@ref9]\], jaw\[[@ref10]\] and so on.

Although 3D printing in modern medicine had many practical cases and has a lot of advantages, it still has many challenges that need to be solved. First, the biocompatible materials for 3D printing in the market are limited and the materials cannot satisfy the specific needs of desired strength, flexibility, and hardness. In addition, the polymerization of 3D printable materials usually involved with hot and organic solvents. The materials did not have good biocompatibility and cannot be used in biomedical and tissue engineering. Although some natural materials such as collagen or gelatin have been applied in 3D printing technology\[[@ref11]\], they cannot provide good mechanical properties and the strength are usually increased by toxic cross-linking agents. Therefore, developing new biocompatible materials or new strategies to enhance the biocompatibility of printed objects is a very important issue.

In the current year, scientists have devoted considerable attention to polydopamine (PDA)-related research\[[@ref12]\]. PDA has the excellent adhesive force to bind with various substrates containing plastics, oxides, noble metals, ceramics and so on, and it can also supply secondary reactivity for conjugating molecules\[[@ref13]-[@ref15]\]. It provides a new strategy through simple chemistry to modify various substrates and increase the function and biocompatibility of substrates\[[@ref16]-[@ref18]\]. In 2014, Wu's group showed self-assembled Ca-P/PDA composite nanolayers can modify the surface of materials and provide the bioactivity for bone regeneration\[[@ref19]\]. In our previous study, we also demonstrated the angiogenesis and osteogenesis of human mesenchymal stem cells (hMSCs) cultured on the polycaprolactone scaffold with PDA-coated/hydroxyapatite (HA) precipitate can be promoted\[[@ref20]\].

In this study, PDA-coated/HA precipitate was modified on the objects printed with the commercial PolyJet photopolymers (MED610), which only support short-term mucosal-membrane contact of up to 24 h. The modified objects had greater biocompatibility and better osteogenesis ability. These results pointed out that this strategy can increase the biocompatibility of printed objects and facilitate the development of 3D printing in biomedicine.

2. Materials and Methods {#sec1-2}
========================

2.1 MED610 3D Printed Object Fabrication {#sec2-1}
----------------------------------------

The 3D printed objects were through SolidWorks (Dassault Systemes SolidWorks Corp., USA) and fabricated by a Stratasys Objet500 Connex3 PolyJet printer (Objet/Stratasys, USA) with MED610 biocompatible photopolymers (Objet/Stratasys, USA). The objects were printed with a thickness of 3 mm and a diameter of 6 mm for the evaluation of mechanical properties and with a thickness of 3 mm and a diameter of 6 mm for the biological test. The uncured photopolymers were washed away, and the objects were post cured under UV light to obtain fully cured objects. In addition, the objects were washed again for cell culture.

2.2 PDA Coating and HA Mineralization {#sec2-2}
-------------------------------------

The PDA was deposited onto the MED610 3D printed objects by direct immersion coating. The objects were immersed in a solution of dopamine hydrochloride (Acros Organics) (2 mg/mL in 10 mM Tris, pH 8.5) for PDA coating, shaken at 25 rpm for 12 h at room temperature, and then rinsed several times with deionized water and dried. For HA crystal mineralization, the objects were treated with calcium and phosphate solution. 10× simulated body fluid (SBF) solution was chosen to initiate uniform nucleation and growth. A stable stock solution of NaH~2~PO~4~.H~2~O (1.198 g), NaCl (58.44 g), KCl (0.375 g), CaCl~2~·2H~2~O (1.016 g), and MgCl~2~·6H~2~O (3.675 g) at pH of about 4.1 was prepared and then added NaHCO~3\ (~0.84 g) was added to adjust the pH to about 6.3. The objects were immersed in 10×SBF at room temperature for 1 h.

2.3 Characterization {#sec2-3}
--------------------

Using X-ray diffractometry (XRD; Bruker D8 SSS, Karlsruhe, Germany) at 30 kV and 30 mA with a scanning speed of 1o/min., the phase composition of the objects with or without coatings was analyzed and the concentration of the measured elements was given in atomic percent. Besides, the scanning electron microscope (SEM) images of the samples were obtained with a SEM (SEM; JSM-6700F, JEOL) operated in the lower secondary electron image mode at 3 kV accelerating voltage. Furthermore, the hardness of the samples was evaluated by the Vickers hardness test.

2.4 Cell Proliferation {#sec2-4}
----------------------

All samples were immersed in 75% ethanol and exposed to UV light for 30 min for sterilization before cell experiments. The hMSCs were obtained from Sciencell Research Laboratories (Sciencell, Carlsbad, CA) and cultured with mesenchymal stem cell culture medium (Sciencell) at 37°C in a 5% CO~2~ atmosphere. Cell suspensions at a density of 10^4^ cells/sample were directly seeded on each sample. The cells were cultured on tissue culture plates without materials (control, Ctl) or the objects with or without coatings for different days and the cell viability was evaluated by the PrestoBlue^®^ (Invitrogen, NY, USA) assay. The optical density was obtained in a multi-well spectrophotometer (Hitachi, Tokyo, Japan) at 570 nm with a reference wavelength of 600 nm.

2.5 Cell Morphology {#sec2-5}
-------------------

After 12 h of cell culture, the samples with hMSCs were washed with cold PBS and fixed by 1.5% glutaraldehyde (Sigma-Aldrich, MO, USA) for 2 h and then were dehydrated by a graded ethanol series for 20 min at each concentration and dried with liquid CO~2~ by a critical point dryer device (LADD 28000, LADD, Williston, VT, USA). The dried samples were mounted on stubs, coated with gold particles, and investigated by SEM (JEOL JSM-7401F, Tokyo, Japan).

2.6 Osteogenesis Assay {#sec2-6}
----------------------

After 3 and 7 days of cell culture, the level of alkaline phosphatase (ALP) activity was evaluated using p-nitrophenyl phosphate (pNPP, Sigma) as the substrate. The samples were mixed with pNPP in 1 M diethanolamine buffer for 15 min, then stopped by the addition of 5N NaOH and quantified by absorbance at 405 nm. The experiments were performed in triplicate.

2.7 Statistical Analysis {#sec2-7}
------------------------

A one-way variance statistical analysis was used to evaluate the significance of the differences between the groups in each experiment. Scheffe's multiple comparison test was used to determine the significance of the deviations in the data for each specimen. In all cases, the results were considered statistically significant with *P*\<0.05.

3. Results {#sec1-3}
==========

3.1 The Physical and Chemical Characterization of PDA/HA Scaffolds {#sec2-8}
------------------------------------------------------------------

Biocompatible materials for 3D printing on the market are limited and the material does not meet the specific needs of the desired hardness, strength, and flexibility. In this study, we used the commercial PolyJet photopolymers (MED610) as the test samples to investigate if PDA/HA coating can enhance the biocompatibility of printed objects and facilitate to improve the applicability of commercial materials.

[Figure 1](#F1){ref-type="fig"} shows the images of printed objects without and with PDA coating. The printed object coated with PDA exhibited black color and this result indicated that we have successfully modified the PDA to the surface of the object.

![The images of the top view of printed objects without (M) and with (MP) PDA coating. The thickness of the objects is 3 mm and a diameter of 6 mm.](IJB-5-197-g001){#F1}

The XRD patterns of the MED610 object (M), the MED610 object with HA (MHA), the prepared PDA-coated object (MP), and the PDA/HA-coated object (MPHA) are shown in [Figure 2](#F2){ref-type="fig"}. M and MP have no peaks. The peaks of MHA and MPHA at around 2θ=25.7° and 2θ=31.9° are characteristic of HA precipitates, which occurs during the early mineral phase of bone development and fracture healing\[[@ref21]\]. The result shows the PDA/HA-coated MED610 object contains a large amount of HA precipitate.

![The wide-range X-ray diffractometry patterns of MED610 (M), MED610 with HA coating (MHA), MED610 with PDA coating (MP), and MED610 with PDA/HA coating (MPHA).](IJB-5-197-g002){#F2}

[Figure 3](#F3){ref-type="fig"} shows the SEM results of MED610 object with HA, PDA, or PDA/HA coatings. The PDA/HA coated object presents more HA mineral crystallization. Based on these results, it is speculated that the PDA coating can effectively assist the bionics of HA mineralization, thereby producing a hybrid biomaterial having HA. In addition, the addition of a PDA/HA coating can increase the hardness of the printed object ([Figure 4](#F4){ref-type="fig"}).

![Surface scanning electron microscope images of the MED610 substrate with various coatings.](IJB-5-197-g003){#F3}

![Vickers hardness of the MED610 substrate with various coatings.](IJB-5-197-g004){#F4}

3.2 Cell Proliferation and Morphology {#sec2-9}
-------------------------------------

Whether the biomedical materials printed by the 3D printer can be widely used in the medical field, the biocompatibility of materials is extremely important. The cell proliferation of the hMSCs cultured on M, MP, MHA, and MPHA for 1, 3, and 7 days was evaluated by PrestoBlue assay ([Figure 5](#F5){ref-type="fig"}). The result shows that absorbance of MED610 object with PDA coatings (MP and MPHA) is higher than Ctl and without PDA coatings (M and MHA). Besides, the MED610 object without any coatings shows the lowest absorbance. In addition, the hMSCs cultured on MED610 object with both PDA coatings reveals a higher area of cell adhesion and are flat with an intact, well-defined morphology ([Figure 6](#F6){ref-type="fig"}). These results point that MED610 object with PDA coatings can improve its biocompatibility, making it more suitable as a biomedical material.

![The cell proliferation of human mesenchymal stem cells cultured on the MED610 substrate with various coatings for 1, 3, and 7 days.](IJB-5-197-g005){#F5}

![Surface scanning electron microscope images of human mesenchymal stem cells cultured on the MED610 substrate with various coatings. Cells are indicated by red arrows.](IJB-5-197-g006){#F6}

3.3 Osteogenic Differentiation {#sec2-10}
------------------------------

The hMSCs cultured on M, MP, MHA, and MPHA for 3 and 7 days were analyzed the ALP activity to evaluate the osteogenic differentiation potential which is an important key to determine if the bone formation process is ongoing. [Figure 7](#F7){ref-type="fig"} shows cells growing on MPHA can express the most ALP levels, and the ALP expression level of MED610 object without coatings was lowest. The results demonstrate that MED610 object with PDA/HA coating helps to improves the osteogenic differentiation potential of stem cells.

![Alkaline phosphatase activity of human mesenchymal stem cells cultured on the MED610 substrate with various coatings for 3 and 7 days.](IJB-5-197-g007){#F7}

4. Discussion {#sec1-4}
=============

MED610 is a biocompatible 3D printing photocurable material commonly used in medical and dental fields requiring precise visualization and patient contact. Although this material is suitable for over 30 days' skin contact and up to 24 h mucosal membrane or bone contact, it can be more widely used if it can be enhanced its biocompatibility and be promoted the potential of cell bone differentiation. Previous studies reported that PDA coatings on biological materials could facilitate cell attachment and promote cell proliferation\[[@ref22],[@ref23]\]. When HA was added in PDA coatings, the phenomenon of cell calcium deposition was significantly promoted\[[@ref20]\]. This means that the PDA/HA coatings can help to enhance osteogenic differentiation. In this study, the PDA/HA coatings were applied in MED610 objects. The results show that the biocompatibility, cell morphology, and bone differentiation potential of the cells cultured on the MED610 objects with PDA/HA coating can be improved. This study demonstrates that PDA/HA coating applications also have similar functions\[[@ref20]\] on objects printed with MED610 materials to enhance their applicability.

5. Conclusion {#sec1-5}
=============

This study shows that using the PDA/HA coating added to the MED610 biomedical 3D printing material that has been used in the medical field can improve its hardness, HA mineralization, cell proliferation, good cell morphology, and the amount of ALP expression. Therefore, the PDA/HA coating enhances the potential and development of MED610 materials for clinical applications in orthopedics and dentistry.
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